Arginine vasopressin release by acetylcholine or norepinephrine: Region-specific and cytokine-specific regulation

Neuroscience

Volumn 71, Issue 3, 1996, Pages 747-759

  Raber, J ^a,b   Bloom, F E ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amygdala; cGMP; Hypothalamus; IFN ; Nitric oxide; TGF 1

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; ACETYLCHOLINE; ALPHA INTERFERON; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DIBUTYRYL CYCLIC GMP; INTERLEUKIN 2; NORADRENALIN; TRANSFORMING GROWTH FACTOR BETA;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; VASOPRESSIN RELEASE;

EID: 0030063945     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00517-X     Document Type: Article

References (90)

1. Akiyama H., Ikeda K., Katoh M., McGeer E. G. and McGeer P. L. (1994) Expression of MRP14, 27E10, interferon-α and leucocyte common antigen by reactive microglia in postmortem human brain tissue. J. Neuroimmun. 50, 195-201.
2. Balkwill F. R. (1989) Peptide regulatory factors: interferons. Lancet i, 1060-1063.
3. Berkenbosch F., van Oers J., Del Rey A., Tilders F. and Besedovsky H. (1987) Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238, 524-526.
4. Berkenbosch F., de Goeij D. E. C., Del Rey A. and Besedovsky H. O. (1989) Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology 50, 570-576.
5. Brandt E. R., Mackay I. R., Hertzog P. J., Cheetham B. F., Sherrit M. and Bernard C. C. (1993) The demonstration of intermittent interferonaemia in patients with multiple sclerosis prompted a molecular analysis of brain. J. Neuroimmun. 44, 1-5.
6. Bredt D. S., Hwang P. M. and Snyder S. H. (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770.
7. Bredt D. S. and Snyder S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. natn. Acad. Sci. U.S.A. 86, 9030-9033.
8. Brune B. and Lapetina E. G. (1989) Activation of a cytosolic ADP-ribosyltransferase by nitric oxide generating agents. J. biol. Chem. 264, 8455-8458.
9. Butt E., van Bemmelen M., Fischer L., Walter U. and Jastorff B. (1990) Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates. Fedn Eur. biochem. Socs Lett. 263, 47-50.
10. Calogero A., Bernardini R., Margloris A. N., Bagdy A. N., Galucci W. T., Munson P. J., Tamarkin L., Tomai T. P., Bray L., Gold P. W. and Chrousos P. (1989) Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 10, 189-200.
11. 3H-phosphoinositides mediated by muscarinic receptors in the developing chick retina: inhibition of carbachol-induced response by glutamate receptors. J. Neurochem. 64, 1064-1070.
12. Chelbi-Alix M. K., Brouard, A., Boissard C., Pelaprat D., Rostene W. and Thang M. N. (1994) Induction by vasoactive intestinal peptide of interferon α/β synthesis in glial cells but not in neurons. J. cell. Physiol. 158, 47-54.
13. Cooper J. R., Bloom F. E. and Roth R. H. (1991) In The Biochemical Basis of Neuropharmacology, 6th edn. Oxford University Press, New York.
14. Cooper K., Naylor A. M and Veale W. L. (1987) Evidence supporting a role for endogenous vasopressin in fever suppression in the rat. J. Physiol. 387, 163-172.
15. 1) expression and regulation in rat cortical astrocytes. J. Neuroimmun. 36, 157-169.
16. Dimmeler S., Lottspeich F. and Brune B. (1992) Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J. biol. Chem. 267, 16771-16774.
17. Dinarello C. A., Bernheim H. A., Duff G. S., Le H.V., Nagabhushan T. L., Hamilton N. C., and Coceani F. (1984) Mechanisms of fever induced by recombinant human interferon. J. clin. Invest. 74, 906-913.
18. Duman R. S., Terwilliger R. Z. and Nestler E. J. (1991) Endogenous ADP-ribosylation in brain: initial characterization of substrate proteins. J. Neurochem. 57, 2124-2132.
19. Dunn J. D. and Whitener J. (1986) Plasma corticosterone responses to electrical stimulation of the amygdaloid comples: cytoarchitectual specificity. Neuroendocrinology 42, 211-217.
20. Farkilla M., Ivanainen M., Roine R., Bergstrom L., Laaksonen R., Niemi M. L. and Cantell K. (1984) Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta neurol. scand. 69, 42-46.
21. Feige J. J., Cochet C. and Chambaz E. M. (1986) Type β transforming growth factor is a potent modulator of differentiated adrenocortical cell functions. Biochem. biophys. Res. Commun. 139, 693-700.
22. Fleisch J. H., Haisch K. D., Spaethe S. M., Rinkema L. E., Cullinan G. J., Schmidt M. J. and Marshall W. S. (1984) Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release. J. Pharmac. exp. Ther. 229, 681-689.
23. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
24. Garthwaite J. (1993) Nitric oxide signalling in the nervous system. Semin. Neurosci. 5, 171-180.
25. Garthwaite J., Charles S. L. and Chess-Wiliams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336, 385-388.
26. Gisslinger H., Svoboda T., Clodi M., Gilli B., Ludwig H., Havelec L. and Luger A. (1993) Interferon-α stimulates the hypothalamo-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 57, 489-495.
27. Goldstein G. and Borden E. C. (1988) Interferons and neurologic disease: epilogue. In Interferon Treatment of Neurological Disorders (ed. Smith R. A.), pp. 321-331. Marcel Dekker, New York.
28. Gomperts B. D. (1990) GE: a GTP-binding protein mediating exocytosis. A Rev. Physiol. 52, 591-606.
29. Gray D. W., Whitnam E. M., Challiss R. A. J. and Nahorski S. R. (1995) Muscarinic cholinoceptor-stimulated synthesis and degradation of inositol 1,4,5-triphosphate in the rat cerebellar granule cell. J. Neurochem. 64, 1143-1151.
30. Gray T. S., Carney M. E. and Magnuson D. J. (1989) Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 50, 433-446.
31. Gushchin G. V., Jakovleva E. E., Kataeva G. V., Korneva E. A., Gajewski M., Grabczewska E., Laskowska-Bozek H., Maslinski W. and Ryzewski J. (1994) Muscarinic cholinergic receptors of rat lymphocytes: effect of antigenic stimulation and local brain lesion. Neuroimmunomodulation 1, 259-264.
32. Gutterman J. U. (1994) Cytokine therapeutics: lessons from interferon α. Proc. natn. Acad. Sci. U.S.A. 91, 1198-1205.
33. Hashimoto K., Suemaru S., Takao T., Sugawara M., Makino S., and Fensuka O. (1988) Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Regul. Peptides 23, 117-126.
34. Hauger R., Millan M. A., Lorang M., Harwood J. P. and Aguilera G. (1988) Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology 123, 396-405.
35. Henry Y., Lepoivre M., Drapier J.-C. Ducrocq C., Boucher J.-L. and Guissani A. (1993) EPR characterization of molecular targets for NO in mammalian cells and organelles. Fedn Am. Socs exp. Biol. J. 7, 1124-1134.
36. Hori T. N. T., Take S. K. Y., Mori T. and Katafuchi Y. (1991) Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res. Bull. 27, 309-313.
37. Hotta M. and Baird A. (1986) Differential effects of transforming growth factor type β on the growth and function of adrenocortical cells in vitro. Proc. natn. Acad. Sci. U.S.A. 83, 7795-7799.
38. House C. and Kemp B.E. (1987) Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 238, 1726-1728.
39. Ishizuka J., Beauchamp R. D. and Townsend C. M., Jr (1993) Novel action of transforming growth factor β 1 in functioning human pancreatic carcinoid cells. J. cell. Physiol 156, 112-118.
40. 1. J. IFN Res. 13, 143-151.
41. Kiefer R., Supler M. L., Toyka K. V. and Streit W. J. (1994) In situ detection of transforming growth factor-β mRNA in experimental rat glioma and reactive glial cells. Neurosci. Lett. 166, 161-164.
42. 1 null mutation in mice causes excessive inflammatory response and early death. Proc. natn. Acad. Sci. U.S.A. 90, 770-774.
43. Lightman S. L. (1994) How does the hypothalamus respond to stress? Semin. Neurosci. 6, 215-219.
44. Lohmann S. M., Walter U., Miller P. E., Greengard P. and De Camilli P. (1981) Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc. natn. Acad. Sci. U.S.A 78, 653-657.
45. Magnuson D. J. and Gray T. S. (1988) Amygdala directly innervates parvocellular paraventricular hypothalamic CRF, vasopressin and oxytocin containing cells. Soc. Neurosci. Ahstr. 14, 1288.
46. Marczin N., Ryan U. S. and Catravas J. D. (1992) Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J. Pharmac. exp. Ther. 263, 170-179.
47. 2 in serum and cerebrospinal fluid. Cancer Treatment Rep. 68, 1057-1058.
48. Mayer H. B., Brunner F. and Schmidt K. (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmac. 45, 367-374.
49. Menzies R. A., Phelps C. P., Chen L. T., Hall N. R. S., Oliver J., Poole L.. Horvath E. and Wiranowska M. (1994) Neuroimmunomodulatory effects of interferon. In Abstracts of the Society for Neuroscience 1994, 392.3. 2, 954, Miami Beach, Florida.
50. Merimsky O., Reider-Groswasser I., Inbar M. and Chaitnik S. (1990) Interferon-related mental deterioration and behavioral changes in patients with renal cell carcinoma. Eur. J. Cancer 26, 596-600.
51. Merrill J. E., Ignarro L. J.. Sherman M. P., Melinek J. and Lane T. E. (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immun. 151, 2132-2141.
52. Misko T. P., Moore W. M., Kasten T. P., Nickols G. A., Corbett J. A., Tilton R. G., McDaniel M. L., Williamson J. R. and Currie M. G. (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmac. 233, 119-125.
53. Mori T. T. S. and Hori T. K. T. (1993) Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation. Am. J. Physiol. 265, R453-459.
54. Muller H., Hammes E., Hiemke C. and Hess G. (1991) Interferon-α-induced stimulation of ACTH and cortisol secretion in man. Neuroendocrinology 54, 499-503.
55. Mulsch A., Busse R., Liebau S. and Forestermann U. (1988) LY83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharmac. exp. Ther. 247, 283-288.
56. Nakanishi S., Maeda N. and Mikoshiba K. (1991) Immunohistochemical localization of an inositol 1,4,5-trophosphate receptor, P400 in neural tissue: studies in developing and adult mouse brain. J. Neurosci. 11, 2075-2086.
57. 1. J. Immun. 146, 1849-1857.
58. Nolten W. E., Goldstein D., Lindstrom M., McKenna M. V., Carlson I. H., Trump D. L., Schiller J., Borden E. C. and Ehrlich E. N. (1993) Effect of cytokines on the pituitary-adrenal axis in cancer patients. J. IFN Res. 13, 349-357.
59. Paxinos P. and Watson C. (1986) In The Rat Brain in Stereotaxic Coordinates. Academic Press, Australia.
60. Pfeffer L. M. and Strulovici B. (1992) Transmembrane secondary messengers for IFN α/β. In Interferon: Principles and Medical Applications, pp. 151-160. Galveston, TX.
61. Pfeilschifter J. and Vosbeck K. (1991) Transforming growth factor ß2 inhibits interleukin 1β-and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem. biophys. Res. Commun. 175, 372-379.
62. 3H] noradrenaline from SH-SY5Y cells. J. Neurochem. 64, 1175-1182.
63. Raber J. and Bloom F. E. (1994) IL-2 induced vasopressin release from the hypothalamus and the amygdala: role of nitric oxide mediated signalling. J. Neurosci.
64. Raber J., Koob G. F. and Bloom F. E. (1995) Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) from the amygdala and involves a nitric-oxide mediated signaling: comparison with the hypothalamic response. J. Pharmac. exp. Ther. 272, 815-824.
65. Raber J., Merlo Pich E., Koob G. F. and Bloom F. E. (1994) IL-1β potentiates the acetylcholine induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala. Neuroendocrinology 59, 208-217.
66. Roberts A. B. and Sporn M. B. (1990) The transforming growth factors-β. In Handbook of Experimental Pharmacology, Peptide Growth Factors and Their Receptors (eds Sporn M. B. and Roberts A. B.), Vol. 95, pp. 419-472. Springer, Heidelberg.
67. Rohatiner A. Z. S., Prior P. F., Burton A. C., Smith A. T., Balkwill F. R. and Lister T. A. (1983) Central nervous system toxicity of interferon. Br. J. Cancer. 47, 419-422.
68. 2. J. Neuroimmun. 12, 311-316.
69. Roth J., Schulze K., Simon E. and Zeisberger E. (1992) Alteration of endotoxin fever and release of arginine vasopressin by dehydration in the guinea pig. Neuroendocrinology 56, 680-686.
70. Sane D. C., Bielawska A., Greenberg C. S. and Hannun Y. A. (1989) Cyclic GMP analogs inhibit γ thrombin-induced arachidonic acid release in human platelets. Biochem. biophys. Res. Commun. 165, 709-714.
71. Saphier D. and Ovadia H. (1990) Selective facilitation of putative corticotropin-releasing factor-secreting neurons by interleukin-1. Neurosci Lett. 114, 283-288.
72. Sapolsky R., Rivier C., Yamamoto G., Plotsky P. and Vale W. (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238, 522-524.
73. Scaccianoce S., Musculo L. A. A., Cighana G., Navarra D., Nicolai R. and Angelucci L. (1991) Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in the rat. Endocrinology 128, 3138-3143.
74. 2+-independent nitric oxide synthase in the myocardum. Br. J. Pharmac. 105, 575-580.
75. Schuman E. M., Meffert M. K., Schulman H. and Madison D. V. (1994) An ADP-ribosyltransferase as a potential target for nitric oxide action in hippocampal long-term potentiation. Proc. natn. Acad. Sci. U.S.A. 91, 11958-11962.
76. 2 in normal volunteers: febrile reactions and changes in circulating corticosteroids and trace metals. Antimicrob. Agents Chemother. 23, 589-592.
77. Shibata M. and Blatteis C. M. (1991) Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis. Brain Res. 562, 323-326.
78. Shiozawa S., Kuroki Y., Kim M., Hirohata S. and Ogino T. (1992) Interferon-α in lupus psychosis. Arthritis Rheum. 35, 417-422.
79. Singh V. B., Onaivi E. S., Phan T. H. and Boadlibiber M. C. (1990) The increases in rat cortical and midbrain tryptophan hydroxylase activity in response to acute or repeated sound stress are blocked by bilateral lesions to the central nucleus of the amygdala. Brain Res. 530, 49-53.
80. Skowsky W., Rosembloom A. A. and Fisher D. A. (1974) Radioimmunoassay of arginine vasopressin in serum: development and application. J. clin. Endocrinol. Metab. 38, 278-287.
81. Snyder S. H. (1994) More jobs for that molecule. Nature 372, 504-505.
82. Spinedi E., Hadid R., Daneva T. and Gaillard R. C. (1992) Cytokines stimulate the CRH but not the vasopressin neuronal system; evidence for a median eminence site of interleukin-6 action. Neuroendocrinology 56, 46-53.
83. Tada T., Yabu K. and Kobayashi S. (1993) Detection of active form of transforming growth factor-β in cerebrospinal fluid of patients with glioma. Jpn. J. Cancer Res. 84, 544-548.
84. Unsicker K., Flanders K. C., Cissel D. S., Lafyatis R. and Sporn M. B. (1991) Transforming growth factor β isoforms in the adult rat central and peripheral nervous system. Neuroscience 44, 613-625.
85. Wahl S. M., Allen J. B., McCartney-Francis N., Morganti-Kossmann M. C., Kossman T., Ellingworth L. and Mai U. E. (1991) Macrophage and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. exp. Med. 173, 981-991.
86. Watenobe H. and Takebe K. (1993) Intrahypothalamic perfusion with interleukin-1β stimulates the local release of corticotropin-releasing hormone and arginine vasopressin and the plasma adrenocorticotropin in freely moving rats: a comparative perfusion of the paraventricular nucleus and the median eminence. Neuroendocrinology 57, 593-599.
87. Weitzman R., Glatz T. H. and Fisher D. A. (1978) The effects of hemorrhage and hypertonic saline upon plasma oxytocin and arginine vasopressin in conscious dogs. Endocrinology 103, 2154.
88. Wesselingh S. L., Gough N. M., Finlay-Jones J. J. and McDonald P. J. (1990) Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymphokine Res. 9, 177-185.
89. Whitnall M., Perlstein R. S., Mougey E. H. and Neta R. (1992) Effect of interleukin-1 on the stress-responsive and nonresponsive subtypes of corticotropin-releasing hormone neurosecretory axons. Endocrinology 131, 37-44.
90. Yau K.-W. (1994) Cyclic nucleotide-gated channels: an expanding new family of ion channels. Proc. natn. Acad. Sci. U.S.A. 91, 3481-3483.